Department of Interventional Cardiology, Clinical Institute S. Ambrogio, IRCCS San Donato, 20149 Milan, Italy.
Circulation. 2013 Mar 26;127(12):1300-7. doi: 10.1161/CIRCULATIONAHA.112.001099. Epub 2013 Feb 26.
Conduction disturbances are relatively common after transcatheter aortic valve implantation. Previous data demonstrated an adverse impact of persistent left bundle-branch block (LBBB) after surgical aortic valve replacement. It is unclear whether new-onset LBBB may also impact the prognosis of patients after transcatheter aortic valve implantation.
Among 1060 patients treated with a CoreValve Revalving System transcatheter aortic valve implantation between October 2007 and April 2011 in high-volume centers in Italy, we analyzed those without LBBB or pacemaker at admission (879 patients [82.9%]). We further excluded those who underwent permanent pacemaker implantation within 48 hours after the procedure (61 patients [7%]), for a final study population of 818 patients. Among them, 224 patients (group A; 27.4%) developed a persistent LBBB and the remaining 594 (group B; 72.6%) did not. Clinical characteristics were similar between groups. A low implantation was significantly more frequent in group A (15% versus 9.8%, P=0.02). No patients were censored before 1 year (median follow-up period 438 days, interquartile range 174-798 days). Survival analyses and inherent log-rank tests showed that LBBB was not associated with higher all-cause mortality, cardiac mortality, or hospitalization for heart failure at 30 days or 1 year. At 30 days, but not at 1 year, group A had a significantly higher rate of pacemaker implantation.
In this registry of high-volume centers, persistent LBBB after CoreValve Revalving System transcatheter aortic valve implantation showed no effect on hard end points. On the other hand, LBBB was associated with a higher short-term rate of pacemaker implantation.
经导管主动脉瓣植入术后传导障碍较为常见。既往数据表明,外科主动脉瓣置换术后持续左束支传导阻滞(LBBB)对预后有不良影响。新出现的 LBBB 是否也会影响经导管主动脉瓣植入术后患者的预后尚不清楚。
在意大利高容量中心接受 CoreValve Revalving System 经导管主动脉瓣植入术的 1060 例患者中(2007 年 10 月至 2011 年 4 月),我们分析了无入院时 LBBB 或起搏器的患者(879 例[82.9%])。我们进一步排除了术后 48 小时内植入永久性起搏器的患者(61 例[7%]),最终研究人群为 818 例。其中,224 例(A 组;27.4%)患者出现持续 LBBB,其余 594 例(B 组;72.6%)未出现。两组间临床特征相似。A 组低植入发生率明显更高(15% vs. 9.8%,P=0.02)。所有患者在 1 年之前均未被删失(中位随访时间 438 天,四分位距 174-798 天)。生存分析和内置对数秩检验显示,LBBB 与 30 天或 1 年时全因死亡率、心脏死亡率或心力衰竭住院率升高无关。A 组在 30 天时的起搏器植入率明显更高,但在 1 年时无差异。
在这个高容量中心的注册研究中,CoreValve Revalving System 经导管主动脉瓣植入术后持续 LBBB 对硬终点无影响。另一方面,LBBB 与短期高起搏器植入率相关。